SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 416 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,691,449 | -44.8% | 23,502 | -33.6% | 0.13% | -32.5% |
| Q1 2023 | $4,875,736 | -37.2% | 35,375 | -41.0% | 0.19% | -33.0% |
| Q4 2022 | $7,764,434 | +656.0% | 59,920 | +545.1% | 0.28% | +691.7% |
| Q3 2022 | $1,027,000 | -66.5% | 9,288 | -77.3% | 0.04% | -60.9% |
| Q2 2022 | $3,070,000 | +357.5% | 40,949 | +449.7% | 0.09% | +253.8% |
| Q4 2021 | $671,000 | -83.8% | 7,450 | -86.0% | 0.03% | -72.6% |
| Q2 2021 | $4,144,000 | -40.3% | 53,300 | +31.0% | 0.10% | -58.7% |
| Q4 2020 | $6,937,000 | – | 40,686 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 290,000 | $44,066,000 | 9.14% |
| Avoro Capital Advisors LLC | 1,400,000 | $212,730,000 | 7.35% |
| NEXTHERA CAPITAL LP | 50,317 | $7,646,000 | 6.37% |
| Eventide Asset Management | 1,123,000 | $170,640,000 | 5.19% |
| RTW INVESTMENTS, LP | 604,236 | $91,814,000 | 4.90% |
| Casdin Capital, LLC | 335,000 | $50,903,250,000 | 4.76% |
| Copernicus Capital Management, LLC | 30,000 | $4,559,000 | 4.06% |
| CADIAN CAPITAL MANAGEMENT, LP | 548,500 | $83,345,000 | 3.76% |
| Dynamic Capital Management Ltd | 4,677 | $711,000 | 3.54% |
| Camber Capital Management LP | 500,000 | $75,975,000 | 3.54% |